Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
08/2003
08/28/2003CA2476822A1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
08/28/2003CA2476665A1 Tricyclic pyrazole derivatives for the treatment of inflammation
08/28/2003CA2476115A1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists
08/28/2003CA2419685A1 Antidiabetic agents
08/27/2003EP1338596A1 Process for producing carbapenem-type antibacterial
08/27/2003EP1338594A1 Pgd2 receptor antagonistic pharmaceutical compositions
08/27/2003EP1337523A2 2,4-substituted pyridine derivatives
08/27/2003EP1337517A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
08/27/2003EP1337256A2 Use of thienopyrimidines
08/27/2003CN1439012A 2-zminoalkyl-thieno [2,3-D] pyrimidines
08/27/2003CN1439003A Arylmethy lamine derivatives for use as tryptase inhibitors
08/27/2003CN1439001A Tetrahydropyridino or piperidino hetlrocyclic derivatives
08/27/2003CN1438993A Ethylenediamine derivatives
08/27/2003CN1438890A 腺苷受体调制剂 Adenosine receptor modulators
08/27/2003CN1119346C Benzothiadiaxoles and derivatives
08/26/2003US6610742 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
08/26/2003US6610684 Fused azepinone cyclin dependent kinase inhibitors
08/26/2003US6610677 Enhancing glycogen synthesis, lowering blood levels of glucose, treating colon, ovarian, or breast cancer, treating diabetes, treating schizophrenia
08/26/2003US6610323 An enteric coated pharmaceutical dosage form comprising an H+,K+- ATPase inhibitor is disclosed. The dosage form comprises at least two portions of the H+,K+- ATPase inhibitor to be released in at least two consecutive pulses.
08/21/2003WO2003068759A1 Piperazine derivatives as anti-inflammatory agents
08/21/2003WO2003068748A1 Novel pyridine- and quinoline-derivatives
08/21/2003US20030158393 Radiolabeled chelation compounds used in pharmaceuticals for diagnostic and therapeutic purposes
08/21/2003US20030158245 Fused heterocyclic derivatives, their production and use
08/21/2003US20030158212 E.g., 5-(3-pyridyl)-cyclohexothieno(2',3'-5,6)pyrimido-(3,4-a)-1,2,4- triazole; intracellular signal transduction; treating glioblastomas and juvenile myelomonocytic leukemia.
08/21/2003US20030158197 Certain alkylene diamine-substituted heterocycles
08/20/2003EP1335988A2 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds
08/20/2003EP1335915A2 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
08/20/2003EP1165566B1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
08/20/2003EP1150944B1 N2-phenylamidine derivatives
08/20/2003CN1437605A Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
08/20/2003CN1437584A Tricyclic protein kinase inhibitors
08/20/2003CN1436779A Cyclic disulfide, producing process thereof and optical products containing the same
08/20/2003CN1118468C Pyrazolopyrimidines and pyrazolotriazines
08/20/2003CN1118460C Pyrimidine derivatives as 5HT2C-receptor antagonists
08/19/2003US6608077 Il-8 receptor antagonists
08/19/2003US6608056 Phosphatidylinositol 3-kinase inhibitors and carcinostatic agents
08/19/2003US6608053 Phosphatidylinositol 3-kinase (PI3K) inhibitors/anticancer agents such as N-(2-(3-benzenesulfonylaminophenyl)-4-morphoniloquinazolin-6-yl)acetamide
08/19/2003CA2079376C (bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
08/14/2003WO2003067259A1 E2 displacement assay for identifying inhibitors of hpv
08/14/2003WO2003066637A1 Polymorphs of clopidogrel hydrochloride and their use as antithrombic compounds
08/14/2003WO2003066630A2 Quinolinone derivatives for treating cell proliferation related disorders
08/14/2003WO2003055438A3 Crystalline form i of 2-methyl-4-(4-methyl-1-piperazinyl) 10h thieno [2,3-b][1,5]benzodiazepine
08/14/2003WO2003013655A3 Carbonic anhydrase inhibitors
08/14/2003US20030153750 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
08/14/2003US20030153610 Substituted oxazolidinones and their in the field of blood coagulation
08/14/2003US20030153556 Anticoagulants and antiagglomerants
08/14/2003CA2475637A1 Quinolinone derivatives for treating cell proliferation related disorders
08/13/2003EP1334974A1 Cyclic disulfide compound, process of producing the same and optical product comprising the same
08/13/2003EP1242427B1 Novel piperidine and piperazine derivatives as p2x7 receptor antagonists
08/13/2003EP1222193B1 Imidazole derivatives as phosphodiesterase vii inhibitors
08/13/2003EP1019411A4 Process for synthesizing carbapenem side chain intermediates
08/13/2003EP0987269B1 Salts of optically active sulfoxide derivative
08/13/2003EP0808313B1 Antipsychotic 4-(1h-indolyl-1-yl)-1-substituted piperidine derivatives
08/13/2003EP0588859B1 Imidazo[1,2-a](pyrrolo, thieno or furano)[3,2-d]azepine derivatives, compositions and methods of use
08/13/2003CN1436192A HMG-CoA reductase inhibitors and method
08/13/2003CN1117755C Spiroazabicyclic heterocyclic compounds, method for preparing same and use thereof
08/12/2003US6605632 Affinity for melatonin receptors
08/12/2003US6605303 Oral pharmaceutical extended release dosage form
08/07/2003WO2003064429A1 Thienopyrimidines, process for preparing the same and use thereof
08/07/2003WO2003064428A1 Furano- and thienopyrimidines as neurokinase inhibitors
08/07/2003WO2003064406A1 Resistance-repellent retroviral protease inhibitors
08/07/2003WO2003064403A1 Furanone derivatives
08/07/2003WO2003064387A2 Substituted indoles as alpha-1 agonists
08/07/2003WO2003063874A1 Condensed heterocyclic compounds
08/07/2003WO2003063873A1 Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno(2, 3-d)-pyrimidine for treating of urinary incontinence
08/07/2003WO2003063779A2 Selective analgesic agents
08/07/2003WO2003051362A3 Polymorphs of clopidogrel hydrogensulfate
08/07/2003WO2002048150A3 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
08/07/2003US20030149278 Method for preparing (+)-biotine
08/07/2003US20030149046 Pyrazoline derivative or tetrahydropyridazine derivative and medicinal use thereof
08/07/2003US20030149028 Pesticidal compositions
08/07/2003CA2474871A1 Furanone derivatives
08/07/2003CA2474851A1 Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno(2, 3-d)-pyrimidine for treating of urinary incontinence
08/07/2003CA2474434A1 Condensed heterocyclic compounds
08/07/2003CA2474306A1 Selective analgesic agents
08/07/2003CA2473803A1 Substituted indoles as alpha-1 agonists
08/07/2003CA2473231A1 Resistance-repellent retroviral protease inhibitors
08/06/2003EP1332147A1 Thieno[2,3-c isoquinolines for use as inhibitors of parp
08/06/2003EP1332133A1 Metabotropic glutamate receptor antagonists
08/06/2003EP1165544B1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
08/06/2003EP0934321B1 Thienopyrimidine with phosphodiesterase v inhibiting effect
08/06/2003CN1434827A 新的哌啶和哌嗪衍生物 The new piperidine and piperazine derivatives
08/06/2003CN1434822A Substituted oxazolidinones and their use in the field of blood coagulation
08/05/2003US6602888 Use of α1C specific compounds to treat benign prostatic hyperplasia
08/05/2003US6602871 Thrombin or factor Xa inhibitors
08/05/2003US6602864 Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
08/05/2003US6602863 Irreversible inhibitors of tyrosine kinases
08/05/2003CA2088798C Condensed imidazopyridine derivatives
07/2003
07/31/2003WO2003062241A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
07/31/2003WO2003062192A1 Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors
07/31/2003WO2002040471A9 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
07/31/2003US20030144562 Hetero diels-alder adducts of pentacene as soluble precursors of pentacene
07/31/2003US20030144504 Dialkyl-halogenophenyl-substituted ketoenols
07/31/2003US20030144276 Heterocycle-containing carboxylic acid derivative and drug containing the same
07/31/2003US20030144274 Preferential enzyme inhibitors such as 3-(4-Methoxyphenyl)-prop-1-ynyl)-N-(4-carboxybenzyl)benzamide, used for prophylaxis of degenerative diseases including cancer and arthritis
07/31/2003US20030144175 Protease inhibitors
07/31/2003CA2471342A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
07/30/2003EP1331223A1 Method of treating sepsis
07/30/2003EP0958296B1 Heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
07/30/2003EP0946558B1 Ethylidene derivatives of tricyclic carbapenems
1 ... 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 ... 214